Japanese Nobel Prize winner Shinya Yamanaka says he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem (iPS) cells in regenerative medicine.
"I want to use artificial intelligence to analyze the enormous amount of data on the human genome and assess the safety (of the cells) in an objective manner and without oversight," Yamanaka said in a recent interview.
Yamanaka, a Kyoto University professor who won the 2012 Nobel Prize in physiology or medicine for his advanced research on iPS cells, was referring to checking for genetic abnormalities before iPS transplants take place to determine whether problems such as cancer could develop later.